tetano
Editor, Senior Moderator
Acta Paediatr
. 2021 Oct 7.
doi: 10.1111/apa.16141. Online ahead of print.
Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine
Qing Chai[SUP] 1 [/SUP], Ulrikka Nygaard[SUP] 2 [/SUP], Rebecca Catherine Schmidt[SUP] 1 [/SUP], Tomas Zaremba[SUP] 3 [/SUP], Anne Marie Møller[SUP] 1 [/SUP], Camilla Maria Thorvig[SUP] 1 [/SUP]
Affiliations
Abstract
Multisystem inflammatory syndrome (MIS) in children (MIS-C) is a complication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, while myocarditis is a rare adverse effect to messenger ribonucleic acid (mRNA) SARS-CoV-2 vaccines, especially in males aged 12-17 years.
. 2021 Oct 7.
doi: 10.1111/apa.16141. Online ahead of print.
Multisystem inflammatory syndrome in a male adolescent after his second Pfizer-BioNTech COVID-19 vaccine
Qing Chai[SUP] 1 [/SUP], Ulrikka Nygaard[SUP] 2 [/SUP], Rebecca Catherine Schmidt[SUP] 1 [/SUP], Tomas Zaremba[SUP] 3 [/SUP], Anne Marie Møller[SUP] 1 [/SUP], Camilla Maria Thorvig[SUP] 1 [/SUP]
Affiliations
- PMID: 34617315
- DOI: 10.1111/apa.16141
Abstract
Multisystem inflammatory syndrome (MIS) in children (MIS-C) is a complication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, while myocarditis is a rare adverse effect to messenger ribonucleic acid (mRNA) SARS-CoV-2 vaccines, especially in males aged 12-17 years.